Pharmacokinetic and Metabolic Studies of ADTM: A Novel Danshensu Derivative Confers Cardioprotection by HPLC-UV and LC-MS/MS
Authors:
Open Access
- 21 January 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 53 (6) , 872-878
Abstract
(R)-(3,5,6-Trimethylpyrazinyl) methyl-2-acetoxy-3-(3,4-diacetoxyphenyl) propanoate (ADTM) is a novel Danshensu (DSS) derivative regarded as a potential new agent for the treatment of myocardial ischemia. A validated high performance liquid chromatography (HPLC) approach with a detection limit of 5 ng/mL was used for pharmacokinetic evaluation of ADTM in rat plasma. The intra- and interday precision in terms of relative standard deviation were t1/2 was 34.33 ± 11.51 and 29.94 ± 8.19 min after oral and intravenous administration of 20 mg/kg. In addition, the major metabolites both in vitro and in vivo were 2-hydroxymethy-3,5,6-trimethylpyrazin and DSS. The results indicated that the hydrolysis was the main metabolic pathway of ADTM, and carboxylesterase may play an important role in ADTM's metabolism. The present work provides basic information for ADTM's further preclinical research and DSS's chemical structure modification.Keywords
This publication has 10 references indexed in Scilit:
- A novel Danshensu derivative confers cardioprotection via PI3K/Akt and Nrf2 pathwaysInternational Journal of Cardiology, 2013
- Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: The role of endothelial nitric oxide synthaseClinical and Experimental Pharmacology and Physiology, 2011
- Asymmetric synthesis and biological evaluation of Danshensu derivatives as anti-myocardial ischemia drug candidatesBioorganic & Medicinal Chemistry, 2009
- Protective roles of puerarin and Danshensu on acute ischemic myocardial injury in ratsPhytomedicine, 2007
- Cardiovascular effects of DanshenInternational Journal of Cardiology, 2007
- Retracted: Cardioprotective effects of the combined use of puerarin and Danshensu on acute ischemic myocardial injury in ratsPhytotherapy Research, 2007
- Ligusticum chuanxiong prevents rat pheochromocytoma cells from serum deprivation-induced apoptosis through a protein kinase A-dependent pathwayJournal of Ethnopharmacology, 2007
- Danshen: A versatile Chinese herbal drug for the treatment of coronary heart diseaseInternational Journal of Cardiology, 2006
- Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical UseThe Journal of Clinical Pharmacology, 2005
- Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasmaBiochemical Pharmacology, 2005